NCT00438048View on ClinicalTrials.gov

A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Primary SjogrenSecondary SjogrenXerostomia
Interventions
PROCEDURE

pilocarpine

or secondary symptomatic SS with clinically significant dry mouth were randomized to receive either 5 mg oral Pilocarpine solution (5ml) or artificial saliva (5 ml) 3 times a day for 12 weeks

DRUG

Artificial Saliva

5ml 3 times daily

Trial Locations (1)

Unknown

Unidad Docente Asociada Dermatologia. Escuela de MEdicina Pontificia Universidad Catolica de Chile, Santiago

All Listed Sponsors
collaborator

Formulario MAgistral Farmacias Ahumada

UNKNOWN

lead

Pontificia Universidad Catolica de Chile

OTHER

NCT00438048 - A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment | Biotech Hunter | Biotech Hunter